H101 oncolytic adenovirus
Oncorine is Shanghai Sunway Biotech's oncolytic adenovirus, approved in China in 2005 for nasopharyngeal carcinoma with chemotherapy, the first oncolytic virus approved anywhere in the world.
Overview
H101 (Oncorine) is an E1B-55K-deleted adenovirus derived from the same design as ONYX-015, developed by Shanghai Sunway Biotech. The NMPA (then the SFDA) approved it in November 2005 for late-stage nasopharyngeal carcinoma in combination with chemotherapy, ten years before talimogene laherparepvec became the first oncolytic virus approved in the United States. It is injected into the tumour.
An adenovirus lacking the E1B-55K gene replicates only in cells with a broken p53 pathway, bursting tumour cells and alerting the immune system.
1.H101 oncolytic adenovirus slips into a pocket on its target.
Compare all products across the US, EU, UK, Japan, China and Australia →
Approvals
| Region | Year | Indication |
|---|---|---|
| CN | 2005 | Late-stage nasopharyngeal carcinoma, with chemotherapy |
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Latest papers
topQuery for this drug: (TITLE:"H101 oncolytic adenovirus" OR ABSTRACT:"H101 oncolytic adenovirus" OR TITLE:"H101" OR ABSTRACT:"H101" OR TITLE:"Oncorine" OR ABSTRACT:"Oncorine") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about H101 oncolytic adenovirus, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentBenmelstobart
Shares the tags china, nmpa-approved.
- TreatmentFlumatinib
Shares the tags china, nmpa-approved.
- TreatmentGumarontinib
Shares the tags china, nmpa-approved.
- TreatmentInetetamab
Shares the tags china, nmpa-approved.
- TreatmentIparomlimab and tuvonralimab
Shares the tags china, nmpa-approved.
- TreatmentIruplinalkib
Shares the tags china, nmpa-approved.
- TreatmentLinperlisib
Shares the tags china, nmpa-approved.
- TreatmentMecapegfilgrastim
Shares the tags china, nmpa-approved.